Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Borrow

Showing results (291-300 of 403) with videos related to

Pageof 41
Sort By:
Plos One|March 5, 2013
Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008Caroline L Trotter, Seydou Yaro, Berthe-Marie Njanpop-Lafourcade, et al.
Vaccine|July 14, 2020
Randomized clinical trial of DTaP5-HB-IPV-Hib vaccine administered concomitantly with meningococcal serogroup C conjugate vaccines during the primary infant seriesJennifer L Oliver, Christine Sadorge, Florence Boisnard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Higher Tetanus Toxoid Immunity 2 Years After PsA-TT Introduction in MaliNicole E Basta, Ray Borrow, Abdoulaye Berthe, et al.
The Pediatric Infectious Disease Journal|November 12, 2005
Immunogenicity and immunologic memory of meningococcal C conjugate vaccine in premature infantsClare L Collins, Jens U Ruggeberg, Gail Balfour, et al.
BMC Microbiology|February 23, 2017
Molecular characterization of invasive capsule null Neisseria meningitidis in South AfricaKaristha Ganesh, Mushal Allam, Nicole Wolter, et al.
BMJ Open|October 23, 2020
'Be on the TEAM' Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescentsJeremy Carr, Emma Plested, Parvinder Aley, et al.
BMJ Open|May 9, 2019
B Part of It School Leaver protocol: an observational repeat cross-sectional study to assess the impact of a meningococcal serogroup B (4CMenB) vaccine programme on carriage of <i>Neisseria meningitidis</i>Helen S Marshall, Mark McMillan, Ann Koehler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2018
Antibody Persistence at the Population Level 5 Years After Mass Vaccination With Meningococcal Serogroup A Conjugate Vaccine (PsA-TT) in Burkina Faso: Need for a Booster Campaign?Seydou Yaro, Berthe-Marie Njanpop Lafourcade, Soumeya Ouangraoua, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2019
Thirteen-Valent Pneumococcal Conjugate Vaccine in Children With Acute Lymphoblastic Leukemia: Protective Immunity Can Be Achieved on Completion of TreatmentJessica Bate, Ray Borrow, Julia Chisholm, et al.
The Journal of Infection|October 19, 2025
Current global trends in meningococcal disease control, risk groups and vaccination: Consensus of the Global Meningococcal InitiativeRay Borrow, Dominque A Caugant, Stephen A Clark, et al.
Pageof 41

Showing results (291-300 of 403) with videos related to

Sort By:
Pageof 41
Plos One|March 5, 2013
Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008Caroline L Trotter, Seydou Yaro, Berthe-Marie Njanpop-Lafourcade, et al.
Vaccine|July 14, 2020
Randomized clinical trial of DTaP5-HB-IPV-Hib vaccine administered concomitantly with meningococcal serogroup C conjugate vaccines during the primary infant seriesJennifer L Oliver, Christine Sadorge, Florence Boisnard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Higher Tetanus Toxoid Immunity 2 Years After PsA-TT Introduction in MaliNicole E Basta, Ray Borrow, Abdoulaye Berthe, et al.
The Pediatric Infectious Disease Journal|November 12, 2005
Immunogenicity and immunologic memory of meningococcal C conjugate vaccine in premature infantsClare L Collins, Jens U Ruggeberg, Gail Balfour, et al.
BMC Microbiology|February 23, 2017
Molecular characterization of invasive capsule null Neisseria meningitidis in South AfricaKaristha Ganesh, Mushal Allam, Nicole Wolter, et al.
BMJ Open|October 23, 2020
'Be on the TEAM' Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescentsJeremy Carr, Emma Plested, Parvinder Aley, et al.
BMJ Open|May 9, 2019
B Part of It School Leaver protocol: an observational repeat cross-sectional study to assess the impact of a meningococcal serogroup B (4CMenB) vaccine programme on carriage of <i>Neisseria meningitidis</i>Helen S Marshall, Mark McMillan, Ann Koehler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2018
Antibody Persistence at the Population Level 5 Years After Mass Vaccination With Meningococcal Serogroup A Conjugate Vaccine (PsA-TT) in Burkina Faso: Need for a Booster Campaign?Seydou Yaro, Berthe-Marie Njanpop Lafourcade, Soumeya Ouangraoua, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2019
Thirteen-Valent Pneumococcal Conjugate Vaccine in Children With Acute Lymphoblastic Leukemia: Protective Immunity Can Be Achieved on Completion of TreatmentJessica Bate, Ray Borrow, Julia Chisholm, et al.
The Journal of Infection|October 19, 2025
Current global trends in meningococcal disease control, risk groups and vaccination: Consensus of the Global Meningococcal InitiativeRay Borrow, Dominque A Caugant, Stephen A Clark, et al.
Pageof 41